Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.

<h4>Background</h4>Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50-80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants, low baseline IP-10, and the functionality of HCV-speci...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jonas Söderholm, Jesper Waldenström, Galia Askarieh, Massimo Pilli, Pierre-Yves Bochud, Francesco Negro, Jean-Michel Pawlotsky, Stefan Zeuzem, Carlo Ferrari, Gunnar Norkrans, Rune Wejstål, Johan Westin, Avidan U Neumann, Bart L Haagmans, Magnus Lindh, Gabriele Missale, Kristoffer Hellstrand, Martin Lagging
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2013
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/c0896e787ce34d95bdd38ea0428e8b40
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/c0896e787ce34d95bdd38ea0428e8b40

Documents similaires